共 18 条
[1]
Lahdes K., Kaila T., Salminen L., Et al., Systemic absorption of topically applied ocular atropine, Clin Pharmacol Ther, 44, pp. 310-314, (1988)
[2]
Kaila T., Huupponen R., Salminen L., Et al., Systemic absorption of ophthalmic cyclopentolate, Am J Ophthalmol, 107, pp. 562-564, (1989)
[3]
Salminen L., Review: Systemic absorption of topically applied ocular drugs in humans, J Ocul Pharmacol, 6, pp. 243-249, (1990)
[4]
Physicians Desk Reference for Ophthalmology, (1992)
[5]
Chen K., Poth E.J., Racial differences as illustrated by the mydriatic action of cocaine, euphthalmine, and ephedrine, J Pharmacol, 36, pp. 429-445, (1929)
[6]
Emiru V.P., Response to mydriatics in the African, Br J Ophthalmol, 55, pp. 538-543, (1971)
[7]
Salazar M., Shimada K., Patie P.N., Iris pigmentation and atropine mydriasis, J Pharmacol Exp Ther, 197, pp. 79-88, (1976)
[8]
Ellis P.P., Commonly used eye medications, General Ophthalmology, pp. 63-77, (1992)
[9]
Newell F.W., Ophthalmology: Principles and Concepts, pp. 99-101, (1992)
[10]
Davidson S.I., Systemic effects of eyedrops, Trans Ophthalmol Soc UK, 94, (1974)